The FDA is advising consumers to not buy or use Infinity capsules or Lite Fit USA softgels, products marketed and sold for weight loss.
A laboratory analysis showed these products were found to contain sibutramine. Sibutramine was a Schedule IV substance that was voluntarily withdrawn from the market in October 2010 following evidence supporting potentially serious cardiovascular adverse effects.
Sibutramine may pose a significant risk for patients with prior coronary artery disease, congestive heart failure, arrhythmias, or stroke. These supplements may also pose life-threatening interactions with other medications a consumer may be taking.
For more information call (855) 543-3784 or visit FDA.gov.